From Dealroom · · 40s
SpectaCell spins out of imec with €6M for immune therapy
SpectaCell, a Ghent- and Leiden-based startup, gets €6 million to speed up immune therapy development using semiconductor tech.
In brief
SpectaCell, a Ghent- and Leiden-based startup, gets €6 million to speed up immune therapy development using semiconductor tech. SpectaCell, spun from imec, secured €6 million seed funding to advance immune therapy research with semiconductor-based cell analysis. Originally reported by Dealroom.
SpectaCell spins out of imec
SpectaCell, a Ghent- and Leiden-based startup, launched with €6 million seed financing led by imec.xpand.
Immune therapy platform development
The company builds a cell analysis platform to measure treatment effects on individual cells for cancer and immune diseases.
€6m seed funding for commercialisation
SpectaCell uses the seed money to fund further development and commercialisation with biopharma partners.
“Researchers need to know much earlier which candidates deserve further investment and why”
What it means
SpectaCell, spun from imec, secured €6 million seed funding to advance immune therapy research with semiconductor-based cell analysis.
